Infonative Solutions Limited IPO
IPO Snapshot
- IPO Dates: March 28 – April 3, 2025
- Listing: BSE SME
- Face Value: ₹1 per share
- Price Band: ₹75-79 per share
- Issue Size: 31.28L shares (₹24.71Cr)
- Lot Size: 1,600 shares (Min: ₹1.26L)
Key Dates
- Tentative Allotment: Fri, Apr 4, 2025
- Refunds Initiation: Mon, Apr 7, 2025
- Demat Credit: Mon, Apr 7, 2025
- Tentative Listing Date: Tue, Apr 8, 2025
Company Overview
Infonative Solutions (Est. 2014) provides:
- Custom eLearning Solutions: LMS platforms, AR/VR content, corporate training
- Clients: Fortune 500 companies, Big 4 firms, government agencies
- Products: MindScroll LMS, off-the-shelf courses, eLearning templates
The company provides cutting-edge e-learning delivery services to clients including Fortune 500 companies, Big 4 consulting firms, IT/ITES, education, and government agencies in industries like BFSI, consulting, and FMCG
Financial Highlights (₹Cr)
Period | Sep-24 | Mar-24 | Mar-23 |
Revenue | 11.42 | 18.08 | 20.95 |
PAT | 3.64 | 1.45 | 1.07 |
Net Worth | 13.75 | 10.11 | 8.66 |
Total Borrowing | 1.71 | 1.97 | 2.49 |
IPO Objectives
- To meet the expenses for development of new products, courses and new features in LMS and purchase of laptop.
- To meet the working capital requirements.
Final Verdict
Listing Gains
- Current IPO Market: Bearish sentiment has impacted recent listings.
- Last 10 SME IPOs: Only 2 saw listing gains; majority listed at discount
- GMP Check Recommended: Grey Market Premium (GMP) will be crucial indicator for potential listing performance
- There might be some potential gain but it is not guaranteed in this market situation
Long-Term
- Pros: High-Growth Sector EdTech market expanding at 14-16% CAGR
- Cons: FY24 revenue declined to ₹18.08Cr (from ₹20.95Cr)
- Cons: 2023-2024: Sharp 13.7% decline (despite industry growth)
Action: Wait for post-listing performance; monitor financials statements
Disclaimer: This blog post is for informational purposes only. Please consult your financial advisor before making any investment decisions.
Chandan Pathak
Research Analyst